Neues vom BioCity Campus

Healthcare Market Study China: Pharmaceuticals and Medical Biotechnology

China’s healthcare market is one of the largest in the world. The market for pharmaceuticals and biopharmaceuticals is growing steadily due to the unbridled demand for innovative drugs and diagnostics as well as conventional drugs and generics.

German products are in demand in China, which opens up good business opportunities for local manufacturers. At the same time, the Chinese market is highly regulated. Complex registration and approval procedures, strict regulations on pricing and distribution make it difficult to get started. The study describes the most important aspects of market access for pharmaceuticals and biopharmaceuticals, introduces China’s business culture, makes recommendations for successful market development and provides information on key local partners.

The publication was commissioned by the Export Initiative for the Healthcare Industry and published by Germany Trade & Invest.

You can download the publication here

Source: Federal Ministry for Economic Affairs and Energy of 10.09.2021

Previous News

iDiv: New building of the research center in Leipzig inaugurated

Michael Kretschmer, Bodo Ramelow and Dr Reiner Haseloff – the Ministers President of Saxony, Thuringia and Saxony-Anhalt respectively – together with DFG Secretary General Heide Ahrens, officially opened the new research building of the German Centre for Integrative Biodiversity Research (iDiv) on Wednesday.

Next News

c-LEcta: Drug Master File for the use of the enzyme DENARASE® in the pharmaceutical industry accepted by the US FDA

c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, has announced the submission of a Master File for its best-selling product DENARASE®.